share_log

Alliance Global Partners Maintains Buy on SELLAS Life Sciences Gr, Lowers Price Target to $8

Alliance Global Partners Maintains Buy on SELLAS Life Sciences Gr, Lowers Price Target to $8

Alliance Global Partners维持对Sellas Life Science Gr的买入,将目标价下调至8美元
Benzinga Real-time News ·  2022/11/15 08:12

Alliance Global Partners analyst James Molloy maintains SELLAS Life Sciences Gr (NASDAQ:SLS) with a Buy and lowers the price target from $14 to $8.

Alliance Global Partners分析师詹姆斯·莫洛伊维持赛拉斯生命科学公司(纳斯达克:SLS)的买入态度,并将目标价从14美元下调至8美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发